Cargando…

Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis

OBJECTIVE: To characterise the costs, including for environmental surveillance (ES), of the Global Polio Laboratory Network (GPLN) that provides laboratory support to the Global Polio Eradication Initiative (GPEI). DESIGN AND PARTICIPANTS: We conducted a survey of the network across 92 countries of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duintjer Tebbens, Radboud J, Diop, Ousmane M, Pallansch, Mark A, Oberste, M Steven, Thompson, Kimberly M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347914/ https://www.ncbi.nlm.nih.gov/pubmed/30670511 http://dx.doi.org/10.1136/bmjopen-2018-023290

Ejemplares similares

Global certification of wild poliovirus eradication: insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission
por: Duintjer Tebbens, Radboud J, et al.
Publicado: (2019)

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2018)

Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission
por: Thompson, Kimberly M., et al.
Publicado: (2017)

The potential impact of expanding target age groups for polio immunization campaigns
por: Duintjer Tebbens, Radboud J, et al.
Publicado: (2014)

Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2017)

The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks
por: Diop, Ousmane M., et al.
Publicado: (2017)

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes
por: Thompson, Kimberly M., et al.
Publicado: (2017)

Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
por: Thompson, Kimberly M., et al.
Publicado: (2015)

Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2017)

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2018)

Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

An economic analysis of poliovirus risk management policy options for 2013–2052
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2015)

The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
por: Thompson, Kimberly M., et al.
Publicado: (2015)

How should we prepare for an outbreak of reintroduced live polioviruses?
por: Thompson, Kimberly M, et al.
Publicado: (2017)

Polio in Pakistan: Political, Sociological, and Epidemiological Factors
por: Andrade, Gabriel E, et al.
Publicado: (2018)

Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination
por: Kalkowska, Dominika A, et al.
Publicado: (2015)

Another look at silent circulation of poliovirus in small populations
por: Kalkowska, Dominika A., et al.
Publicado: (2018)

Spinal cord gray matter atrophy is associated with functional decline in post‐polio syndrome
por: Wendebourg, Maria Janina, et al.
Publicado: (2022)

Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative
por: Thompson, Kimberly M., et al.
Publicado: (2022)

Acute flaccid myelitis in a polio-like syndrome
por: Pereira, Ronaldo Gonçalves, et al.
Publicado: (2020)

Healthcare Workers’ Knowledge and Attitude Toward Telemedicine During the COVID-19 Pandemic: A Global Survey
por: Naqvi, Saman Z, et al.
Publicado: (2022)

The impact of disruptions caused by the COVID-19 pandemic on global polio eradication()
por: Kalkowska, Dominika A., et al.
Publicado: (2023)

Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series
por: Shoucri, Sherif M, et al.
Publicado: (2021)

Costs of Illness Due to Cholera, Costs of Immunization and Cost-Effectiveness of an Oral Cholera Mass Vaccination Campaign in Zanzibar
por: Schaetti, Christian, et al.
Publicado: (2012)

Study protocol: characterising the clinical, epidemiological and aetiological aspects of leptospirosis in Sri Lanka: a hospital based clinico-epidemiological study
por: Agampodi, Suneth, et al.
Publicado: (2019)

Infectious Mononucleosis: A Case Report With Unusual Features and Abnormal Laboratory Findings
por: Alli, Ammar, et al.
Publicado: (2021)

Laboratory and Point-of-Care Testing for COVID-19: A Review of Recent Developments
por: Kalia, Ravi, et al.
Publicado: (2022)

Laboratory-Reported Normal Value Ranges Should Not Be Used to Diagnose Periprosthetic Joint Infection
por: Forte, Salvador A, et al.
Publicado: (2022)

The Relationship Between Laboratory Findings and Mortality in COVID-19 Patients Requiring Intensive Care
por: Bahceci, Ilkay, et al.
Publicado: (2023)

Comparison of demographic, clinical and laboratory characteristics between first and second COVID-19 waves in a secondary care hospital in Qatar: a retrospective study
por: Naushad, Vamanjore A, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant Variant
por: Karyakarte, Rajesh P, et al.
Publicado: (2023)

Healthcare costs and outcomes associated with surgical site infections after coronary artery bypass grafting surgeries in Oman
por: AlRiyami, Fatma M., et al.
Publicado: (2023)

An investigation of the effects of the common cold on simulated driving performance and detection of collisions: a laboratory study
por: Smith, Andrew Paul, et al.
Publicado: (2012)

Tracking Progress Toward Polio Eradication — Worldwide, 2013–2014
por: Porter, Kimberly A., et al.
Publicado: (2015)

VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients
por: Conrad, Anne, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fp96jgvg9hera9camuoh651rmt